CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net (loss) income	$ (52,658)	$ 240,423
Adjustments to reconcile net (loss) income to cash provided by (used in) operating activities:
Depreciation and amortization	64,800	57,259
Net amortization of debt premiums, discounts and issuance costs	2,074	2,472
Straight line rental income	(2,448)	(1,745)
Amortization of acquired real estate leases	(311)	105
Loss on modification or early extinguishment of debt	1,075	483
Impairment of assets	5,925	0
Gain on sale of properties	(1,233)	(327,794)
Gains and losses on equity securities, net	(8,126)	8,553
Other non-cash adjustments, net	(674)	(628)
Unconsolidated joint venture distributions	1,411	2,720
Equity in net losses (earnings) of investees	647	(3,354)
Change in assets and liabilities:
Deferred leasing costs, net	(1,954)	(2,568)
Other assets	15,499	21,326
Accrued interest	2,540	15,734
Other liabilities	(20,525)	(20,250)
Net cash provided by (used in) operating activities	6,042	(7,264)
Cash flows from investing activities:
Real estate improvements	(60,292)	(55,791)
Proceeds from sale of properties, net	3,548	252
Proceeds from sale of properties to joint venture, net	0	643,892
Net cash (used in) provided by investing activities	(56,744)	588,353
Cash flows from financing activities:
Repayments of borrowings on credit facility	(250,000)	(100,000)
Repayment of other debt	(538)	(838)
Payment of debt issuance costs	(1,990)	(2,805)
Repurchase of common shares	(6)	(5)
Distributions to shareholders	(2,397)	(2,390)
Net cash used in financing activities	(254,931)	(106,038)
(Decrease) increase in cash and cash equivalents and restricted cash	(305,633)	475,051
Cash and cash equivalents and restricted cash at beginning of period	688,302	1,016,945
Cash and cash equivalents and restricted cash at end of period	$ 382,669	$ 1,491,996